Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SHANGHAI PECHEM
00338
5
SINOPEC CORP
00386
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | -40.45%53.14B | -34.79%22.17B | -25.31%89.23B | -20.05%34B | 2.51%119.46B | -1.89%42.53B | -31.26%116.54B | -45.68%43.35B | 16.03%169.54B | 110.53%79.8B |
| Operating income | -40.45%53.14B | -34.79%22.17B | -25.31%89.23B | -20.05%34B | 2.51%119.46B | -1.89%42.53B | -31.26%116.54B | -45.68%43.35B | 16.03%169.54B | 110.53%79.8B |
| Cost of sales | 45.13%-40.73B | 38.28%-16.77B | 28.13%-74.24B | 22.61%-27.18B | -2.68%-103.3B | -1.21%-35.12B | 28.74%-100.6B | 47.24%-34.7B | -23.27%-141.18B | -125.61%-65.77B |
| Operating expenses | 45.13%-40.73B | 38.28%-16.77B | 28.13%-74.24B | 22.61%-27.18B | -2.68%-103.3B | -1.21%-35.12B | 28.74%-100.6B | 47.24%-34.7B | -23.27%-141.18B | -125.61%-65.77B |
| Gross profit | -17.24%12.4B | -20.89%5.4B | -7.32%14.98B | -7.94%6.83B | 1.44%16.17B | -14.33%7.42B | -43.79%15.94B | -38.33%8.66B | -10.23%28.36B | 60.32%14.03B |
| Selling expenses | 53.38%-1.88B | 39.93%-988.76M | 22.60%-4.03B | 2.02%-1.65B | 6.29%-5.21B | 2.15%-1.68B | 6.38%-5.56B | 37.96%-1.72B | -6.78%-5.94B | -43.97%-2.77B |
| Administrative expenses | 15.43%-2.7B | 20.02%-1.35B | 23.04%-3.19B | 18.05%-1.69B | 20.11%-4.15B | 12.39%-2.06B | -0.87%-5.19B | 8.57%-2.35B | -8.91%-5.15B | -15.32%-2.57B |
| Revaluation surplus | -32.20%-51.6M | -26.18%-83.46M | -267.13%-39.03M | -151.84%-66.14M | -98.40%23.35M | -82.85%127.59M | -47.15%1.46B | 44.01%744.16M | 21.59%2.75B | -2.37%516.76M |
| -Changes in the fair value of investment property | -32.20%-51.6M | -26.18%-83.46M | -267.13%-39.03M | -151.84%-66.14M | -98.40%23.35M | -83.45%127.59M | -47.88%1.46B | 39.75%771.04M | 21.08%2.79B | -6.21%551.72M |
| -Changes in the fair value of other assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 23.14%-26.88M | 6.42%-38.99M | 40.73%-34.97M |
| Impairment and provision | 25.96%-672.38M | -240.78%-101.65M | 24.16%-908.14M | 234.77%72.2M | -182.33%-1.2B | -83.29%21.57M | 9.06%-424.11M | 136.30%129.09M | -194.19%-466.37M | -3,158.86%-355.62M |
| -Other impairment is provision | 25.96%-672.38M | -240.78%-101.65M | 24.16%-908.14M | 234.77%72.2M | -182.33%-1.2B | -83.29%21.57M | 9.06%-424.11M | 136.30%129.09M | -194.19%-466.37M | -3,158.86%-355.62M |
| Special items of operating profit | 109.04%4.36M | 3.32%33.66M | -108.17%-48.21M | -93.65%32.58M | 531.40%590.21M | 290.99%513.14M | -122.45%-136.81M | -31.27%131.24M | -2.67%609.35M | 21.37%190.94M |
| Operating profit | 4.99%7.1B | -17.59%2.91B | 8.65%6.76B | -18.59%3.53B | 2.38%6.22B | -22.43%4.34B | -69.85%6.08B | -38.19%5.59B | -16.08%20.17B | 70.72%9.05B |
| Financing income | -19.31%63.15M | -30.94%33.73M | -73.68%78.27M | -71.15%48.85M | -23.34%297.43M | -12.83%169.3M | -11.55%388.01M | -27.81%194.23M | -21.61%438.69M | -7.38%269.06M |
| Financing cost | 0.35%-2.97B | 12.48%-1.41B | 1.76%-2.98B | -19.06%-1.61B | 19.65%-3.04B | -8.10%-1.36B | -194.86%-3.78B | -14.37%-1.25B | -12.43%-1.28B | -16.18%-1.1B |
| Share of profits of associates | -142.08%-267.89M | -101.99%-3.32M | -8.12%636.58M | -42.66%167.04M | 80.65%692.83M | 276.37%291.32M | -43.66%383.51M | -275.40%-165.18M | -61.13%680.7M | -87.44%94.17M |
| Share of profit from joint venture company | 99.68%-977K | -36.09%128.51M | -135.95%-302M | -35.23%201.09M | 35.37%840.16M | -19.69%310.45M | -55.40%620.66M | -13.44%386.58M | 17.68%1.39B | -3.97%446.59M |
| Earning before tax | -6.45%3.92B | -29.03%1.66B | -16.45%4.19B | -37.80%2.33B | 35.87%5.02B | -21.04%3.75B | -82.73%3.69B | -45.74%4.75B | -18.91%21.4B | 49.46%8.76B |
| Tax | -2.56%-3.6B | 19.10%-763.73M | 35.99%-3.51B | 34.85%-944.04M | -85.88%-5.49B | 19.16%-1.45B | 63.27%-2.95B | 56.29%-1.79B | 21.73%-8.04B | -73.03%-4.1B |
| After-tax profit from continuing operations | -52.82%321.79M | -35.77%893.08M | 246.05%682.1M | -39.66%1.39B | -162.88%-467.03M | -22.17%2.3B | -94.44%742.7M | -36.46%2.96B | -17.11%13.36B | 33.46%4.66B |
| After-tax profit from non-continuing business | ---- | ---- | ---- | ---- | --1.25B | ---- | ---- | ---- | ---- | ---- |
| Special items of earning after tax | ---- | ---- | ---- | ---- | --1.25B | ---- | ---- | ---- | ---- | ---- |
| Earning after tax | -52.82%321.79M | -35.77%893.08M | -13.06%682.1M | -39.66%1.39B | 5.64%784.57M | -22.17%2.3B | -94.44%742.7M | -36.46%2.96B | -17.11%13.36B | 33.46%4.66B |
| Minority profit | -137.53%-71.6M | -53.27%201.53M | 301.41%190.79M | -50.61%431.26M | -120.50%-94.72M | -25.48%873.22M | -90.31%462.03M | -32.85%1.17B | -19.69%4.77B | 0.68%1.74B |
| Profit attributable to shareholders | -19.93%393.39M | -27.91%691.55M | -44.12%491.31M | -32.97%959.24M | 213.28%879.3M | -20.01%1.43B | -96.73%280.67M | -38.62%1.79B | -15.60%8.59B | 65.77%2.91B |
| Basic earnings per share | -14.29%0.06 | -28.57%0.1 | -41.67%0.07 | -30.00%0.14 | 200.00%0.12 | -28.57%0.2 | -97.12%0.04 | -40.43%0.28 | -15.76%1.39 | 67.86%0.47 |
| Diluted earnings per share | -14.29%0.06 | -28.57%0.1 | -41.67%0.07 | -30.00%0.14 | 200.00%0.12 | -28.57%0.2 | -97.10%0.04 | -40.43%0.28 | -16.36%1.38 | 67.86%0.47 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
| Auditor | Grant Thornton (Hong Kong) Limited | -- | Grant Thornton (Hong Kong) Limited | -- | PwC | -- | PwC | -- | PwC | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.